Chao Cheng

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Squamous Cell Carcinoma

Cross Sectional

Top Venues

International journal of cancer

Journal of medical Internet research

Cell death discovery

European journal of nuclear medicine and molecular imaging

中山大学附属第一医院

This page only lists publications with an associated author ORCID identifier.

Affiliation History

中山大学附属第一医院

China

教授 :: 胸外科

Publications

Baishen Zhang, Yao Liu, Zhiting Chen, Jing Chen, Hui Yu, Meichen Li, Shudong Ma, Chao Cheng, Li-Kun Chen
Chemotherapy versus chemotherapy plus immune checkpoint inhibitors for the first-line treatment of unresectable thymic carcinoma: A multicenter retrospective study. International journal of cancer 155 (4) (2024)
Shiyan Wang, Yong Zeng, Lin Zhu, Min Zhang, Lei Zhou, Weixiong Yang, Weishan Luo, Lina Wang, Yanming Liu, Helen Zhu, Xin Xu, Peiran Su, Xinyue Zhang, Musaddeque Ahmed, Wei Chen, Moliang Chen, Sujun Chen, Mykhaylo Slobodyanyuk, Zhongpeng Xie, Jiansheng Guan, Wen Zhang, Aafaque Ahmad Khan, Shingo Sakashita, Ni Liu, Nhu-An Pham, Paul C Boutros, Zun-Fu Ke, Michael F Moran, Zongwei Cai, Chao Cheng, Jun Yu, Ming Sound Tsao, Housheng Hansen He
The N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma. Cancer discovery (2024)
Baishen Zhang, Yao Liu, Zhiting Chen, Jing Chen, Hui Yu, Meichen Li, Shudong Ma, Chao Cheng, Li-Kun Chen
Chemotherapy versus chemotherapy plus immune checkpoint inhibitors for the first-line treatment of unresectable thymic carcinoma: A multicenter retrospective study. International journal of cancer 155 (4) (2024)
Baishen Zhang, Yao Liu, Zhiting Chen, Jing Chen, Hui Yu, Meichen Li, Shudong Ma, Chao Cheng, Li-Kun Chen
Chemotherapy versus chemotherapy plus immune checkpoint inhibitors for the first-line treatment of unresectable thymic carcinoma: A multicenter retrospective study. International journal of cancer (2024)
Xiaoyan Wang, Weixiong Yang, Qian Zhou, Hui Luo, Wenfang Chen, Sai-Ching Jim Yeung, Shuishen Zhang, Yi Gan, Bo Zeng, Zhenguo Liu, Shiting Feng, Xiangsong Zhang, Chao Cheng
The role of <sup>18</sup>F-FDG PET/CT in predicting the pathological response to neoadjuvant PD-1 blockade in combination with chemotherapy for resectable esophageal squamous cell carcinoma. European journal of nuclear medicine and molecular imaging 49 (12) (2022)
Weixiong Yang, Xiangbin Xing, Sai-Ching Jim Yeung, Siyu Wang, Wenfang Chen, Yong Bao, Fang Wang, Shiting Feng, Fang Peng, Xiaoyan Wang, Shuling Chen, Minghui He, Ning Zhang, Honglei Wang, Bo Zeng, Zhenguo Liu, Biniam Kidane, Christopher W Seder, Kazuo Koyanagi, Yaron Shargall, Honghe Luo, Sui Peng, Chao Cheng
Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma. Journal for immunotherapy of cancer 10 (1) (2022)
Bo Zeng, Zhenguo Liu, Haoshuai Zhu, Xin Zhang, Weixiong Yang, Xiaoxing Li, Chao Cheng
CircRNA_2646 functions as a ceRNA to promote progression of esophageal squamous cell carcinoma via inhibiting miR-124/PLP2 signaling pathway. Cell death discovery 7 (1) (2021)
Yan Guo, Chao Cheng, Yu Zeng, Yiran Li, Meng-Ting Zhu, Weixiong Yang, He Xu, Xiaohua Li, Jinhang Leng, Aliza Monroe-Wise, Shaomin Wu
Mental Health Disorders and Associated Risk Factors in Quarantined Adults During the COVID-19 Outbreak in China: Cross-Sectional Study. Journal of medical Internet research 22 (8) (2020)
Chao Cheng, Rainbow Tin Hung Ho, Yan Guo, Meng-Ting Zhu, Weixiong Yang, Yiran Li, Zhenguo Liu, Shuyu Zhuo, Qi Liang, Zhenghong Chen, Yu Zeng, Jiali Yang, Zhanfei Zhang, Xu Zhang, Aliza Monroe-Wise, Sai-Ching Jim Yeung
Development and Feasibility of a Mobile Health-Supported Comprehensive Intervention Model (CIMmH) for Improving the Quality of Life of Patients With Esophageal Cancer After Esophagectomy: Prospective, Single-Arm, Nonrandomized Pilot Study. Journal of medical Internet research 22 (8) (2020)